Entropy Technologies LP acquired a new stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 10,790 shares of the semiconductor company’s stock, valued at approximately $1,004,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. lifted its position in Axcelis Technologies by 85.9% in the fourth quarter. Victory Capital Management Inc. now owns 1,807,404 shares of the semiconductor company’s stock worth $145,207,000 after purchasing an additional 835,242 shares during the period. Invesco Ltd. raised its stake in shares of Axcelis Technologies by 176.6% in the 3rd quarter. Invesco Ltd. now owns 386,735 shares of the semiconductor company’s stock worth $37,761,000 after buying an additional 246,939 shares in the last quarter. Balyasny Asset Management L.P. lifted its holdings in shares of Axcelis Technologies by 10,368.7% in the fourth quarter. Balyasny Asset Management L.P. now owns 243,503 shares of the semiconductor company’s stock valued at $19,563,000 after buying an additional 241,177 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Axcelis Technologies by 142.7% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 266,015 shares of the semiconductor company’s stock valued at $22,909,000 after buying an additional 156,387 shares during the period. Finally, Millennium Management LLC boosted its stake in Axcelis Technologies by 143.8% during the third quarter. Millennium Management LLC now owns 261,776 shares of the semiconductor company’s stock valued at $25,560,000 after buying an additional 154,381 shares in the last quarter. Institutional investors own 89.98% of the company’s stock.
Insider Activity at Axcelis Technologies
In related news, EVP Eileen Evans sold 926 shares of Axcelis Technologies stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $155.51, for a total value of $144,002.26. Following the transaction, the executive vice president owned 31,295 shares of the company’s stock, valued at approximately $4,866,685.45. This trade represents a 2.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Gerald M. Blumenstock sold 1,161 shares of Axcelis Technologies stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $152.70, for a total value of $177,284.70. Following the completion of the transaction, the executive vice president directly owned 20,493 shares in the company, valued at $3,129,281.10. This represents a 5.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 34,795 shares of company stock valued at $5,344,383 over the last ninety days. Company insiders own 0.49% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on ACLS
Axcelis Technologies Price Performance
NASDAQ ACLS opened at $120.03 on Wednesday. Axcelis Technologies, Inc. has a 1 year low of $65.64 and a 1 year high of $193.78. The business’s fifty day moving average is $156.30 and its two-hundred day moving average is $122.42. The stock has a market capitalization of $3.69 billion, a P/E ratio of 37.39, a P/E/G ratio of 9.07 and a beta of 1.88. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.99 and a current ratio of 4.59.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.01. The business had revenue of $198.96 million during the quarter, compared to analyst estimates of $195.03 million. Axcelis Technologies had a return on equity of 12.19% and a net margin of 11.93%.The company’s revenue was up 3.3% compared to the same quarter last year. During the same period last year, the company posted $0.88 EPS. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. On average, research analysts forecast that Axcelis Technologies, Inc. will post 3.21 earnings per share for the current fiscal year.
Axcelis Technologies Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
See Also
- Five stocks we like better than Axcelis Technologies
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
